Skip to main content
. 2016 Jun 8;10:1025–1035. doi: 10.2147/PPA.S102760

Figure 3.

Figure 3

Cost-effectiveness of universal post-treatment testing.

Notes: a100% patient adherence to testing. b86% adherence to UBT and 48% adherence to mFAT.

Abbreviations: ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year; UBT, urea breath test; mFAT, monoclonal fecal antigen test.